Fonte: Carcinogenesis. Unidade: FCF
Assuntos: CARCINOMA HEPATOCELULAR, CARCINOGÊNESE
ABNT
ANDRADE, Fábia de Oliveira et al. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. Carcinogenesis, v. 40, n. 8, p. 979-988, 2019Tradução . . Disponível em: https://doi.org/10.1093/carcin/bgy190. Acesso em: 06 nov. 2024.APA
Andrade, F. de O., Furtado, K. S., Heidor, R., Sandri, S., Hebeda, C. B., Miranda, M. L. P., et al. (2019). Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis. Carcinogenesis, 40( 8), 979-988. doi:10.1093/carcin/bgy190NLM
Andrade F de O, Furtado KS, Heidor R, Sandri S, Hebeda CB, Miranda MLP, Fernandes LHG, Yamamoto RC, Horst MA, Farsky SHP, Moreno FS. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis [Internet]. Carcinogenesis. 2019 ; 40( 8): 979-988.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/carcin/bgy190Vancouver
Andrade F de O, Furtado KS, Heidor R, Sandri S, Hebeda CB, Miranda MLP, Fernandes LHG, Yamamoto RC, Horst MA, Farsky SHP, Moreno FS. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis [Internet]. Carcinogenesis. 2019 ; 40( 8): 979-988.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1093/carcin/bgy190